Publication related to RSI or an RSI staff member
Update on the provisional estimation of developing iatrogenic variant Creutzfeldt-Jakob disease from human islet cell transplantation procedures.
Authors
- Tyshenko, Michael G, Tyshenko MG, 1 McLaughlin Centre for Population Health Risk Assessment, University of Ottawa Ottawa, Ontario, Canada 2 Brain Research Centre University of British Columbia Vancouver British Columbia, Canada 3 PrioNet Canada, Vancouver, British Columbia, Canada 4 Professional Guidelines and Public Health Practice Division, Centre for Infectious Disease Prevention and Control Public Health Agency of Canada Ottawa Ontario, Canada 5 Faculty of Health Sciences, University of Ontario Institute of Technology Oshawa Ontario, Canada 6 Department of Epidemiology and Community Medicine Faculty of Medicine, University of Ottawa Ottawa, Ontario, Canada.
- Bertram, Lisa, Bertram L,
- Li, Li, Li L,
- ElSaadany, Susie, ElSaadany S,
- Samis, John, Samis J,
- Krewski, Daniel, Krewski D,
- Cashman, Neil R, Cashman NR,
YEAR OF PUBLICATION: 2014
SOURCE: Transplantation. 2014 Jun 27;97(12):e73-5. doi: 10.1097/TP.0000000000000176.
JOURNAL TITLE ABBREVIATION: Transplantation
JOURNAL TITLE: Transplantation
ISSN: 1534-6080 (Electronic) 0041-1337 (Linking)
VOLUME: 97
ISSUE: 12
PAGES: e73-5
PLACE OF PUBLICATION: United States
LANGUAGE: eng
DATE OF PUBLICATION: 2014 Jun 27
DATE COMPLETED: 20140808
DATE REVISED: 20140617
MESH DATE: 2014/08/13 06:00
EDAT: 2014/06/17 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1097/TP.0000000000000176 [doi]
OWNER: NLM
Related RSI Experts
Chief Risk Scientist
Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Senior Health Risk Analyst
Dr. Michael G. Tyshenko is a Senior Health Risk Analyst at Risk Sciences International (RSI), where he has contributed since 2018 to the organization’s most complex and cross-cutting public health risk issues. As RSI’s lead on chemical peer reviews, he...